Lovastatin

Product NDC
63629-1019
11-digit product format
636291019
Labeler code
63629
Product ID
63629-1019_c18af9e7-b364-4f53-bd54-13b15797c7b5
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lovastatin
Dosage form
TABLET
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA075991
Marketing category
ANDA
Marketing start
2002-11-25
Marketing end
0000-00-00
Substance
LOVASTATIN
Active strength
20 mg/1
Pharmacologic classes
HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63629-1019-02020-07-10C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1019-12020-07-10C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1019-22020-07-10C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1019-32020-07-10C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1019-52020-07-10C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1019-62020-07-10C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1019-82020-07-10C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1019-02020-01-31C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1019-12020-01-31C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1019-22020-01-31C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1019-32020-01-31C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1019-52020-01-31C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1019-62020-01-31C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M
63629-1019-82020-01-31C16284748780-19d75b9d1-1434-f424-e053-dadaa90a57ceLovastatin Tablet USP Revision M

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
63629-1019-0636291019001000 TABLET in 1 BOTTLE (63629-1019-0) 1000 tablet2019-05-310000-00-00NoNoCurrent
63629-1019-163629101901100 TABLET in 1 BOTTLE (63629-1019-1) 100 tablet2019-05-310000-00-00NoNoCurrent
63629-1019-26362910190230 TABLET in 1 BOTTLE (63629-1019-2) 30 tablet2019-05-310000-00-00NoNoCurrent
63629-1019-363629101903300 TABLET in 1 BOTTLE (63629-1019-3) 300 tablet2019-05-310000-00-00NoNoCurrent
63629-1019-563629101905500 TABLET in 1 BOTTLE (63629-1019-5) 500 tablet2019-05-310000-00-00NoNoCurrent
63629-1019-66362910190660 TABLET in 1 BOTTLE (63629-1019-6) 60 tablet2019-05-310000-00-00NoNoCurrent
63629-1019-863629101908800 TABLET in 1 BOTTLE (63629-1019-8) 800 tablet2019-05-310000-00-00NoNoCurrent